ADH1A and Hypercalciuria: Mouse models with gain-of-function Casr mutations have been generated by chemical mutagenesis and knock-in strategies, and they have been shown to have a phenotype closely resembling ADH1 in humans with hypocalcemia, hyperphosphatemia, reduced PTH concentrations, hypercalciuria, and ectopic calcifications (12, 13).